Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/<i>lpr</i> mice
Atsushi Inoue(Astellas Pharma (Japan)), Shigeru Fujita(Tokyo Medical University), Hitoshi Hasegawa(Tokyo Institute of Psychiatry), Mitsuko R. Ito(Tohoku University), Miho Terada(Ehime University), Masato Nose(Meiji University), Toshio Imai(Shionogi (Japan)), Masashi Kohno(Ehime University), Osamu Yoshie(Waseda University)
Cited by 126
Related Papers
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
|Immunity|1999|2.7k
Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion
|Cell|1997|1.5k
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
Human host factors required for influenza virus replication
|Nature|2009|825
Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion
|Proceedings of the National Academy of Sciences|2002|398